MEDI-9197

• CAT Number: I007943
• CAS Number: 1359993-59-1
• Molecular Formula: C36H59N5O2
• Molecular Weight: 593.90
• Purity: ≥95%
• Synonyms: MEDI-9197; MEDI 9197; MEDI9197; 3M-052; 3M 052; 3M052;N-(4-((4-amino-2-butyl-1H-imidazo[4,5-c]quinolin-1-yl)oxy)butyl)stearamide
• Target: Toll-like Receptor (TLR)
• IUPAC Name: N-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)oxybutyl]octadecanamide
• InChI: InChI=1S/C36H59N5O2/c1-3-5-7-8-9-10-11-12-13-14-15-16-17-18-19-27-33(42)38-28-22-23-29-43-41-32(26-6-4-2)40-34-35(41)30-24-20-21-25-31(30)39-36(34)37/h20-21,24-25H,3-19,22-23,26-29H2,1-2H3,(H2,37,39)(H,38,42)
• InChIKey: RRTPWQXEERTRRK-UHFFFAOYSA-N
• SMILES: CCCCCCCCCCCCCCCCCC(=O)NCCCCON1C(=NC2=C1C3=CC=CC=C3N=C2N)CCCC

MEDI-9197（Cat No.:I007943）is a synthetic immune agonist designed to activate toll-like receptors (TLR7 and TLR8), which play a crucial role in the innate immune response. This compound is being investigated for its potential in treating viral infections and certain cancers by enhancing the body’s immune response. By stimulating TLR pathways, MEDI-9197 promotes the production of cytokines and other immune modulators that enhance antiviral and antitumor activity. It is a promising candidate in immunotherapy research, targeting diseases that benefit from immune system activation and modulation.